日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial

齐来贝西兰辅助治疗控制不佳的高血压:KARDIA-2 随机临床试验

Desai, Akshay S; Karns, Adam D; Badariene, Jolita; Aswad, Ahmad; Neutel, Joel M; Kazi, Farhana; Park, Wansu; Stiglitz, Daniel; Makarova, Nune; Havasi, Andrea; Zappe, Dion H; Saxena, Manish

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients

既往用药情况及血管紧张素转换酶抑制剂联合钙通道阻滞剂治疗高危高血压患者的心血管获益

Brook, Robert D; Kaciroti, Niko; Bakris, George; Dahlöf, Björn; Pitt, Bertram; Velazquez, Eric; Weber, Michael; Zappe, Dion H; Hau, Tsushung; Jamerson, Kenneth A

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

根据收缩压对糖尿病患者和非糖尿病患者心血管结局的影响:一项 ACCOMPLISH 子研究

Weber, Michael A; Bloch, Michael; Bakris, George L; Weir, Matthew R; Zappe, Dion H; Dahlof, Bjorn; Velazquez, Eric J; Pitt, Bertram; Basile, Jan N; Jamerson, Kenneth; Hua, Tsushung A

Time of administration important? Morning versus evening dosing of valsartan

给药时间重要吗?缬沙坦的晨服与晚服哪个更好?

Zappe, Dion H; Crikelair, Nora; Kandra, Albert; Palatini, Paolo

Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial

无论基线脉压如何,氨氯地平+贝那普利均优于氢氯噻嗪+贝那普利:ACCOMPLISH试验的亚组分析

Skoglund, Per H; Svensson, Per; Asp, Joline; Dahlöf, Björn; Kjeldsen, Sverre E; Jamerson, Kenneth A; Weber, Michael A; Jia, Yan; Zappe, Dion H; Östergren, Jan

Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients

血管紧张素受体阻滞剂/利尿剂联合疗法对肥胖、高血压的非裔美国人和白人患者的降压和代谢影响

Ofili, Elizabeth O; Zappe, Dion H; Purkayastha, Das; Samuel, Rita; Sowers, James R

Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?

RAS阻断对血清K+水平的影响是否会影响其与氢氯噻嗪联合使用时的降血糖作用?

Deedwania, Prakash C; Zappe, Dion H; Egan, Brent M; Purkayastha, Das; Samuel, Rita; Sowers, James R

Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen

高血压绝经后妇女主动脉脉搏波速度的变化:钙通道阻滞剂与血管紧张素受体阻滞剂治疗方案的比较

Hayoz, Daniel; Zappe, Dion H; Meyer, Marie A R; Baek, Inyoung; Kandra, Albert; Joly, Marie P; Mazzolai, Lucia; Haesler, Erik; Periard, Daniel

Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients

在肥胖高血压患者中,缬沙坦/氢氯噻嗪联合疗法与氢氯噻嗪单药疗法在诊室和动态血压降低方面的疗效比较

Raij, Leopoldo; Egan, Brent M; Zappe, Dion H; Purkayastha, Das; Samuel, Rita; Sowers, James R

Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives

血管紧张素受体阻滞剂/利尿剂联合用药可维持肥胖高血压患者的胰岛素反应。

Sowers, James R; Raij, Leopoldo; Jialal, Ishwaral; Egan, Brent M; Ofili, Elizabeth O; Samuel, Rita; Zappe, Dion H; Purkayastha, Das; Deedwania, Prakash C